117 related articles for article (PubMed ID: 32314121)
1. Cardiac MR manifestations in two cases of PRKAG2 mutations in a Chinese family.
Wang J; Li X; Xu Y
Int J Cardiovasc Imaging; 2020 Aug; 36(8):1527-1531. PubMed ID: 32314121
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
[TBL] [Abstract][Full Text] [Related]
3. A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation.
Yang KQ; Lu CX; Zhang Y; Yang YK; Li JC; Lan T; Meng X; Fan P; Tian T; Wang LP; Liu YX; Zhang X; Zhou XL
Sci Rep; 2017 May; 7(1):2407. PubMed ID: 28546535
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic expression and clinical outcomes in a South Asian PRKAG2 cardiomyopathy cohort.
Ahamed H; Balegadde AV; Menon S; Menon R; Ramachandran A; Mathew N; Natarajan KU; Nair IR; Kannan R; Shankar M; Mathew OK; Nguyen TT; Gupta R; Stawiski EW; Ramprasad VL; Seshagiri S; Phalke S
Sci Rep; 2020 Nov; 10(1):20610. PubMed ID: 33244021
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.
Liu Y; Bai R; Wang L; Zhang C; Zhao R; Wan D; Chen X; Caceres G; Barr D; Barajas-Martinez H; Antzelevitch C; Hu D
PLoS One; 2013; 8(5):e64603. PubMed ID: 23741347
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
7. Rare forms of preexcitation: a case study and brief overview of familial forms of preexcitation.
Koneru JN; Wood MA; Ellenbogen KA
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):e82-7. PubMed ID: 22895604
[No Abstract] [Full Text] [Related]
8. High throughput phenotyping of left and right ventricular cardiomyopathy in calcineurin transgene mice.
Moreth K; Afonso LC; Fuchs H; Gailus-Durner V; Katus HA; Bekeredjian R; Lehman L; Hrabě de Angelis M
Int J Cardiovasc Imaging; 2015 Apr; 31(4):669-79. PubMed ID: 25627778
[TBL] [Abstract][Full Text] [Related]
9. Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
Ramratnam M; Sharma RK; D'Auria S; Lee SJ; Wang D; Huang XY; Ahmad F
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092788
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.
Maron BJ; Ho CY
JACC Cardiovasc Imaging; 2009 Jan; 2(1):65-8. PubMed ID: 19356535
[No Abstract] [Full Text] [Related]
11. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
12. Glycogen Storage Disease Because of a PRKAG2 Mutation Causing Severe Biventricular Hypertrophy and High-Grade Atrio-Ventricular Block.
Yogasundaram H; Paterson ID; Graham M; Sergi C; Oudit GY
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27496753
[No Abstract] [Full Text] [Related]
13. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
[TBL] [Abstract][Full Text] [Related]
14. Mutations in
Salazar-Mendiguchía J; Ochoa JP; Palomino-Doza J; Domínguez F; Díez-López C; Akhtar M; Ramiro-León S; Clemente MM; Pérez-Cejas A; Robledo M; Gómez-Díaz I; Peña-Peña ML; Climent V; Salmerón-Martínez F; Hernández C; García-Granja PE; Mogollón MV; Cárdenas-Reyes I; Cicerchia M; García-Giustiniani D; Lamounier A; Gil-Fournier B; Díaz-Flores F; Salguero R; Santomé L; Syrris P; Olivé M; García-Pavía P; Ortiz-Genga M; Elliott PM; Monserrat L;
Heart; 2020 Sep; 106(17):1342-1348. PubMed ID: 32451364
[TBL] [Abstract][Full Text] [Related]
15. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome.
Fabris E; Brun F; Porto AG; Losurdo P; Vitali Serdoz L; Zecchin M; Severini GM; Mestroni L; Di Chiara A; Sinagra G
J Am Coll Cardiol; 2013 Aug; 62(9):e17. PubMed ID: 23810891
[No Abstract] [Full Text] [Related]
17. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
[TBL] [Abstract][Full Text] [Related]
18. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.
Lopez-Sainz A; Dominguez F; Lopes LR; Ochoa JP; Barriales-Villa R; Climent V; Linschoten M; Tiron C; Chiriatti C; Marques N; Rasmussen TB; Espinosa MÁ; Beinart R; Quarta G; Cesar S; Field E; Garcia-Pinilla JM; Bilinska Z; Muir AR; Roberts AM; Santas E; Zorio E; Peña-Peña ML; Navarro M; Fernandez A; Palomino-Doza J; Azevedo O; Lorenzini M; García-Álvarez MI; Bento D; Jensen MK; Méndez I; Pezzoli L; Sarquella-Brugada G; Campuzano O; Gonzalez-Lopez E; Mogensen J; Kaski JP; Arad M; Brugada R; Asselbergs FW; Monserrat L; Olivotto I; Elliott PM; Garcia-Pavia P;
J Am Coll Cardiol; 2020 Jul; 76(2):186-197. PubMed ID: 32646569
[TBL] [Abstract][Full Text] [Related]
20. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
Tan HL; van der Wal AC; Campian ME; Kruyswijk HH; ten Hove Jansen B; van Doorn DJ; Oskam HJ; Becker AE; Wilde AA
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):276-81. PubMed ID: 19808419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
